Jr. Robert E. Funck - 29 Feb 2024 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
29 Feb 2024
Net transactions value
-$1,370,371
Form type
4
Filing time
04 Mar 2024, 19:00:37 UTC
Previous filing
23 Feb 2024
Next filing
14 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability $1,370,371 -11,415 -5.1% $120.05 211,341 29 Feb 2024 Direct
holding ABT Common shares without par value 20,000 29 Feb 2024 By Trust F1
holding ABT Common shares without par value 20,000 29 Feb 2024 By Trust F1
holding ABT Common shares without par value 18,765 29 Feb 2024 Profit Sharing Trust F2
holding ABT Common shares without par value 500 29 Feb 2024 By Daughter F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of March 1, 2024.
F3 The reporting person disclaims beneficial ownership of all securities held by his daughter.